BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
Kara N. Maxwell(Philadelphia VA Medical Center), Katherine L. Nathanson(Translational Therapeutics (United States))
Cited by 308
Related Papers
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
|Nature|2010|1.8k
Network modeling links breast cancer susceptibility and centrosome dysfunction
|Nature Genetics|2007|634
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|519